Posted on Wednesday, August 26, 2015 at 9:50 am CDT
The Verishow Telehealth solution is the ideal solution for health care providers as well as pharmaceutical companies that wish to interact in person with patients. Advanced Gastroenterology of Bergen County is a Professional Corporation owned and operated by five board certified physicians specializing in Internal Medicine and Gastroenterology. The practice resides in a suburb of New Jersey only 4 miles from New York City. The practice serves a multicultural patient population from every socioeconomic background. Medical practices are highly competitive in this area and patient demands are great. VeriShow was incorporated into the practice to offer a sophisticated technology solution to help improve patient access to the services. Rather than relying on telephone connection to gain entrance and schedule consultations, follow up visits, and procedures, VeriShow offered a platform via the website for patients and staff to text chat, video chat, and share content regarding registration, insurance eligibility, medical procedures, upcoming visits, diagnostic testing, and a variety of medical treatments. VeriShow quickly improved patient access and decreased endless phone calls that often left patients on hold and decrease access and satisfaction.
Source: Sari M Cicurel
Posted on Tuesday, August 25, 2015 at 8:15 am CDT
Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems. Multiple sclerosis can be broadly classified into four types: RRMS, SPMS, PPMS, and PRMS.
Source: Fast Market Research
Posted on Friday, August 21, 2015 at 2:31 pm CDT
35 million men and 21 million women in the US are experiencing the thinning of hair and hair loss. InnerWhealth Solutions has launched a natural product that will help to combat hair loss. The product provides healthy hair growth support at the cellular level by nourishing hair follicles.
Source: in2town
Posted on Friday, August 21, 2015 at 10:10 am CDT
Global Pharmacy Automation market to grow at a CAGR of 7.01 percent over the period 2014-2019. Pharmacy automation system is an effective tool to minimize prescription errors and ensure patient safety. It is a system to automate workflow process and eliminate medication errors during packaging and dispensing in the field of medicine and healthcare. Pharmacy automation involves medicine counting, mixing and measuring liquids and powders for compounding, updating customer database, and inventory management. While maintaining accuracy level, the system can bring new business without hiring and training new staff.
Source: Market Research Store
Posted on Friday, August 21, 2015 at 8:11 am CDT
Phosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and aluminum-free, calcium-free phosphate binders are used to treat the condition.
Source: Fast Market Research
Posted on Thursday, August 20, 2015 at 12:59 pm CDT
Plasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other components that can be used for the treatment of various diseases. The separation of plasma from the blood is done by a process known as plasmapheresis. Plasma therapeutics are utilized in the treatment of rare, life-threatening, chronic, and genetic diseases, such as immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, and infectious diseases such as tetanus, hepatitis, and rabies.
Source: Fast Market Research
Posted on Thursday, August 20, 2015 at 11:33 am CDT
Membranes are a type of selective barrier that are primarily used for separation or concentration of the feed stream. The feed stream is passed through the membrane that selectively allows some constituents to pass, while others are retained back on the surface of the membrane, depending on its pore size. The constituents that are allowed to pass are known as permeate and the ones retained back are known as concentrate or retentate. Different types of membrane are used in the pharmaceutical industry depending on their pore size. There are many technologies implemented for these membranes, including ultrafiltration, microfiltration, reverse osmosis, and nanofiltration.
Source: Fast Market Research
Posted on Tuesday, August 18, 2015 at 2:21 pm CDT
Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today the appointment of Felix Garzon, MD, Ph.D. to the position of Senior Vice President, Head of Clinical Development effective August 17, 2015. Dr. Garzon brings with him 28 years of pertinent pharmaceutical and biotechnology experience in increasingly senior roles, most recently at Eisai and Bristol-Myers Squibb, having worked on both later and earlier stages of drug development.
Source: Actinium Pharmaceuticals, Inc.
Posted on Tuesday, August 18, 2015 at 9:28 am CDT
Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy.
Source: Fast Market Research
Posted on Tuesday, August 18, 2015 at 9:00 am CDT
Recent incidents that question the integrity of compounded drugs administered to subjects in several cities reinforces the need for fuller licensing and fraud control for all such companies, say representatives for AbsoluteRX, a Lutz, Florida based firm and website. The call for tighter approval comes in the wake of cases such as the Moses Lake compounded pharmacy in Washington in late July, who recalled unexpired human and veterinary compounded drugs due to concerns about their sterility. The US government also reached a settlement with a Jacksonville pharmacy in July for $8.4 million, to resolve allegations of unscrupulous practices by that facility.
Source: Seo Gladiator
Posted on Tuesday, August 18, 2015 at 8:15 am CDT
XareltoCares.com is a newly launched website that has been established to inform readers of Xarelto blood thinner uses and bleeding side effects. The main objective of the website is to spread knowledge and educate people to empower them to take informed decisions when regarding the popular blood thinning drug use. The website is being managed by a group of writers who have accumulated a vast range of information through impressive research skills allow them to search out the answers to the most pressing concerns about the use and side effects of Xarelto. The blog recently shared an article about Xarelto Lawsuits that were filed as a result of the side effects caused by the drug.
Source: PR Apex
Posted on Monday, August 17, 2015 at 9:00 am CDT
Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series C: e-Books on Cancer & Oncology
Source: Leaders in Pharmaceutical Business Intelligence
Posted on Friday, August 14, 2015 at 9:15 am CDT
GlobalData's clinical trial report, "Candidiasis Global Clinical Trials Review, H1, 2015" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Source: Fast Market Research
Posted on Friday, August 14, 2015 at 8:30 am CDT
GlobalData's clinical trial report, "Epistaxis Global Clinical Trials Review, H1, 2015" provides an overview of Epistaxis clinical trials scenario. This report provides top line data relating to the clinical trials on Epistaxis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Source: Fast Market Research
Posted on Wednesday, August 12, 2015 at 12:02 pm CDT
This e-Book is a comprehensive review of recent Original Research on METABOLOMICS and related opportunities for Targeted Therapy written by Experts, Authors, Writers. This is the first volume of the Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases. It is written for comprehension at the third year medical student level, or as a reference for licensing board exams, but it is also written for the education of a first time baccalaureate degree reader in the biological sciences. Hopefully, it can be read with great interest by the undergraduate student who is undecided in the choice of a career. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012. All new articles on this subject, will continue to be incorporated, as published with periodical updates.
Source: Leaders in Pharmaceutical Business Intelligence
Posted on Wednesday, August 12, 2015 at 9:13 am CDT
Seahorse Bioscience Labware, a global leader in the design, engineering, and manufacture of high-performance microplate products announces a name change to reflect the company's focus on custom, off-the-shelf microplates for life science applications. Seahorse Microplates has proven expertise in the high-precision molding and production of custom filter, storage, and reservoir microplates. The new name reinforces the advancements that the company has undergone to continue developing microplates that meet, and exceed industry standards and different application requirements.
Source: Agilent Microplates
Posted on Friday, August 07, 2015 at 5:13 pm CDT
Pharmaceutical compounding is becoming very popular in the Los Angeles area, and ABC Compounding Pharmacy is one of the few establishments professionally licensed by the state of California. The friendly and courteous ABC pharmacists specifically design each compounded medication with the unique health needs of the individual patient in mind. By carefully selecting the proper medications in the precise amounts, patients can gain a speedier recovery without the sometimes negative side effects.
Source: ABC Compounding Pharmacy
Posted on Tuesday, August 04, 2015 at 8:45 am CDT
GlobalData's clinical trial report, "Nasal Obstruction Global Clinical Trials Review, H1, 2015" provides an overview of Nasal Obstruction clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Obstruction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Source: Fast Market Research
Posted on Tuesday, August 04, 2015 at 8:44 am CDT
GlobalData's clinical trial report, "Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Source: Fast Market Research
Posted on Wednesday, July 29, 2015 at 8:49 am CDT
Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some of the common types of autoimmune diseases are ankylosing spondylitis, Crohn's disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.
Source: Fast Market Research
Posted on Tuesday, July 28, 2015 at 8:30 am CDT
Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market.
Source: Fast Market Research
Posted on Friday, July 17, 2015 at 10:56 am CDT
For all those people who wish to make a career in pharmaceutical or medical sales, www.howtogetintopharmaceuticalsales.com/ has several useful videos to help the purpose. These contain step by step methods which have been proved to be effective in the field and since there is a lot of competition in this field, they can be considered by those who want to break in.
Source: Beuses USA Inc
Posted on Friday, July 17, 2015 at 8:36 am CDT
Based in Pennsylvania, very conveniently located around the industry-rich Croydon region, the General Partition Company provides a wide variety of box dividers, separators and partitions that are specialized for each industry contracting services with them. Right now, the company is announcing that they are available to provide box partitions and dividers specifically for the pharmaceutical industry.
Source: General Partition Company Inc.
Posted on Thursday, July 16, 2015 at 11:30 am CDT
A new herbal medicine of Fuyan Pill was released by Wuhan Dr. Lee's TCM Clinic in 2009. This was really good news for all endometriosis patients as well as other females with reproductive problems. Through over 6 years of many clinical cases on endometriosis since the release of this pill, it approves that Fuyan pill can completely cure this disease and makes it possible for patients to get rid of the side effects of pain relievers and the physical damage brought by surgeries.
Source: Wuhan Dr. Lee's TCM clinic
Posted on Thursday, July 16, 2015 at 5:30 am CDT
Actinium Pharmaceuticals, Inc.("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has submitted a request for a pre-IND (Investigative New Drug) meeting to the U.S. Food and Drug Administration (FDA) for the company's Iomab-B drug candidate currently preparing to commence the pivotal Phase 3 trial. During the early development of a new drug, manufacturers are required to apply for and obtain IND designation.
Source: Actinium Pharmaceuticals, Inc.